Add this topic to your myFT Digest for news straight to your inbox
Merger of US groups will create $18bn clinical trials and data specialist
A merger of equals is not always about slashing costs
US approvals of new medicines show significant increase
The stratagem of stimulating the body’s immune system has found its moment
The wave of blockbuster drugs losing patent protection peaks this year
International Edition